MAPT and early-onset autosomal dominant Alzheimer disease: Additionally, by decreasing the activation of insulin-dependent protein phosphatases and increasing the activity of glycogen synthase kinase 3β (GSK-3β), insulin resistance can hinder the clearance of amyloid beta and promote tau hyperphosphorylation, directly connecting insulin resistance to the pathological hallmarks of Alzheimer’s disease [204,205].